GlassScriptPhysician profile
Stacey M Olliff
NPI 1720309057
$4,474.84
in general payments reported to CMS, 2019-2025
35 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,851 · 2020: $1,122 · 2021: $1,250 · 2022: $251.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $793.70 | 2019-2021 | |
| Abbvie INC. | $541.84 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $452.88 | 2019-2021 | |
| Astellas Pharma US INC | $417.72 | 2019-2021 | |
| Novo Nordisk INC | $355.31 | 2019-2021 | |
| Lilly USA, LLC | $222.05 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $148.97 | 2019-2021 | |
| Amarin Pharma, INC. | $148.12 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $130.25 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $105.02 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $94.00 | 2019-2020 | |
| Eisai INC. | $80.11 | 2020-2021 | |
| Upsher-Smith Laboratories LLC | $78.51 | 2020-2021 | |
| Phadia US INC. | $71.13 | 2019-2021 | |
| Pfizer INC. | $66.97 | 2019-2021 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $65.50 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $63.27 | 2021 | |
| Smith+Nephew, INC. | $58.75 | 2019 | |
| Merck Sharp & Dohme LLC | $57.58 | 2019-2021 | |
| Dexcom, INC. | $50.39 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $48.91 | 2021 | |
| Janssen Pharmaceuticals, INC | $47.66 | 2019-2020 | |
| Genentech USA, INC. | $45.64 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $44.43 | 2019-2020 | |
| Horizon Therapeutics Plc | $44.25 | 2020-2021 | |
| Glaxosmithkline, LLC. | $41.74 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $37.98 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.86 | 2021 | |
| Clarus Therapeutics INC. | $25.28 | 2021 | |
| Sanofi-Aventis U.S. LLC | $23.06 | 2019 | |
| Bardy Diagnostics, INC. | $23.00 | 2021 | |
| Bausch Health US, LLC | $21.44 | 2021 | |
| Antares Pharma, INC. | $14.73 | 2021 | |
| Medtronic, INC. | $12.63 | 2021 | |
| Mylan Specialty L.P. | $12.16 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey Olliff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.